Overview

Myriad RBM, Inc. is the world’s leading multiplexed immunoassay testing laboratory, providing comprehensive protein biomarker services based on its Multi-Analyte Profiling (MAP) technology platform. This platform provides pre-clinical and clinical researchers with reproducible and quantitative data for a few or hundreds of proteins in a cost-effective manner. All services are performed in our CLIA certified laboratory. As a guide to drug development researchers, Myriad RBM also offers companion diagnostic, custom assay development, co-sponsored research programs, and innovative cell culture products and services.

Myriad RBM’s CLIA certified biomarker testing laboratory, is located in Austin, TX. Myriad RBM is a wholly owned subsidiary of Myriad Genetics, Inc. (MYGN), a leading molecular diagnostic company based in Salt Lake City, Utah which develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests.

883

Publications Cited

300

Quantitative Immunoassays

35519699

Data Points Generated

587715

Samples Tested

Quality Policy

Myriad RBM is committed to the highest level of quality in our product. Quality and customer satisfaction shall underlie all of our efforts.

Certifications

Myriad RBM has earned CLIA licensure of accreditation from COLA, participates in external proficiency testing programs from CAP, and is capable of supporting Good Laboratory Practice (GLP) studies.

Employment

Myriad RBM’s CLIA certified biomarker testing laboratory is located in Austin, TX. Myriad RBM is a wholly owned subsidiary of Myriad Genetics, Inc.

LATEST PRESS